CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
Author:
Affiliation:
1. Department of Molecular & Immunology, Chinese PLA General Hospital, Beijing, China
2. Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing, China
3. Department of 3Geriatric Hematology, Chinese PLA General Hospital, Beijing, China
Funder
National Key Research and Developement Program of Chinas
Science and Technology Planning Project of Beijing City
Publisher
Informa UK Limited
Subject
Oncology,Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1440169
Reference41 articles.
1. Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy
2. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
3. Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia
4. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
5. Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
Cited by 217 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advances and considerations in the use of immunotherapies for primary hepato-biliary malignancies;Surgical Oncology;2024-02
2. Intraperitoneal administration of carcinoembryonic antigen-directed chimeric antigen receptor T cells is a robust delivery route for effective treatment of peritoneal carcinomatosis from colorectal cancer in pre-clinical study;Cytotherapy;2024-02
3. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs;Experimental Hematology & Oncology;2024-01-22
4. Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence;Cells;2024-01-04
5. Colorectal cancer stem cells: overview and potential targeted therapy;Cancer Stem Cells and Signaling Pathways;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3